KYLE HORTON-MASER: Open Payments
NPI 1558754044 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,302 in 145 payments from 17 companies in 2025. Trend: 2023 $2,959 · 2024 $2,741 · 2025 $2,302
Food & beverage: $2,302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $283 |
| Janssen Biotech, Inc. | 11 | $270 |
| GENZYME CORPORATION | 10 | $269 |
| UCB, Inc. | 14 | $201 |
| Novartis Pharmaceuticals Corporation | 36 | $196 |
| Lilly USA, LLC | 6 | $192 |
| PFIZER INC. | 8 | $165 |
| Amgen Inc. | 8 | $158 |
| Galderma Laboratories, L.P. | 15 | $156 |
| Organon LLC | 6 | $154 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, CIBINQO, OTEZLA, NEMLUVIO, EBGLYSS.
Industry payments across NY — which companies pay providers there.
